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Pulsed-field gel electrophoresis (PFGE) was applied to the study of the similarity of 55 strains of proteolytic
Clostridium botulinum (C. botulinum group I) types A, AB, B, and F. Rare-cutting restriction enzymes ApaI, AscI,
MluI, NruI, PmeI, RsrII, SacII, SmaI, and XhoI were tested for their suitability for the cleavage of DNA of five
proteolytic C. botulinum strains. Of these enzymes, SacII, followed by SmaI and XhoI, produced the most
convenient number of fragments for genetic typing and were selected for analysis of the 55 strains. The
proteolytic C. botulinum species was found to be heterogeneous. In the majority of cases, PFGE enabled
discrimination between individual strains of proteolytic C. botulinum types A and B. The different toxin types
were discriminated at an 86% similarity level with both SacII and SmaI and at an 83% similarity level with
XhoI. Despite the high heterogeneity, three clusters at a 95% similarity level consisting of more than three
strains of different origin were noted. The strains of types A and B showed higher diversity than the type F
organisms which formed a single cluster. According to this survey, PFGE is to be considered a useful tool for
molecular epidemiological analysis of proteolytic C. botulinum types A and B. However, epidemiological
conclusions based on PFGE data only should be made with discretion, since highly similar PFGE patterns were
noticed, especially within the type B strains.
The most commonly reported forms of botulism are food-
borne botulism, wound botulism, and infant botulism. Food-
borne botulism is an intoxication caused by consumption of
preformed botulinum neurotoxin, while wound and infant bot-
ulism are both infections in which neurotoxin is formed in vivo
(13). Proteolytic Clostridium botulinum (C. botulinum group I)
is one of six phylogenetically and physiologically distinct clos-
tridia that forms botulinum neurotoxin. It is responsible for a
majority of the cases of infant botulism and wound botulism as
well as many cases of classical food-borne botulism (1, 2, 4, 16,
17). Nonproteolytic C. botulinum (C. botulinum group II) is
responsible for most other cases of food-borne botulism (13).
The confirmation of food-borne botulism outbreaks has been
based on the detection of botulinum toxin or C. botulinum
organisms of the same toxin type from both the patient and the
suspected food item. In order to be able to confirm the epide-
miological relatedness of the strains isolated from patients and
from food, a method for genotyping proteolytic C. botulinum
isolates is needed. Such a method would also be of utility when
investigating cases of wound or infant botulism.
Since the first paper on pulsed-field gel electrophoresis
(PFGE) typing of C. botulinum type A strains Hall A and 62 A
was published (10), no reports on the genetic diversity of
strains of proteolytic of C. botulinum as determined by PFGE
have been published. With nonproteolytic C. botulinum, a high
genetic diversity determined by PFGE and randomly amplified
polymorphic DNA (RAPD) analysis has been reported (5, 6, 8,
9). These methods have been used as tools for epidemiological
analysis of strains of nonproteolytic C. botulinum (6, 9, 11).
However, RAPD analysis could not separate strains of proteo-
lytic C. botulinum types A and F below the serotype level (8).
Furthermore, the discriminatory power of repetitive element
sequence-based PCR with proteolytic C. botulinum was even
lower than that of RAPD (8). Based on these results, it was
concluded that proteolytic C. botulinum might be a more ho-
mogeneous species than nonproteolytic C. botulinum (8).
To extend our knowledge of the biodiversity of proteolytic
C. botulinum and to evaluate the usefulness of PFGE in the
genotyping of this organism, strains of proteolytic C. botulinum
from various origins were studied using an optimized PFGE
protocol.
MATERIALS AND METHODS
C. botulinum strains. A total of 55 C. botulinum strains from culture collections
of the Department of Food and Environmental Hygiene, University of Helsinki,
Helsinki, Finland, and the Institute of Food Research, Norwich, United King-
dom, were used to determine the genetic diversity of proteolytic C. botulinum. Of
these strains, 19 were of type A, 28 were of type B, and 3 were of type F, whereas
5 strains contained the toxin gene for both types A and B. The strains included
both European and American isolates. The sources of the strains are shown in
Table 1. Each of the strains, ATCC 3502, ATCC 19397, ATCC 7948, NCTC
2012, ATCC 25763, ATCC 25764, and ATCC 35415, were initially obtained from
more than one laboratory (Table 1). The proteolytic activity of the strains was
confirmed by plating on reinforced Clostridium medium containing 5% (vol/wt)
skim milk (15).
DNA preparations. After being incubated anaerobically at 37°C for 2 days,
single colonies of pure cultures were picked from blood agar plates and inocu-
lated into 10 ml of tryptone-peptone-glucose-yeast extract broth (Difco Labora-
tories, Detroit, Mich.) and incubated for 16 h at 37°C. DNA isolation was
performed according to a previously described method (5), with slight modifi-
cations. A 4-ml volume of the 16-h culture was chilled on ice, and cells were
harvested by centrifugation (1,100  g) at 4°C and suspended in PIV buffer (10
mM Tris [pH 7.5], 1 M NaCl) supplemented with 10% (vol/vol) formaldehyde
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TABLE 1. Proteolytic Clostridium botulinum strains included in the study
Strain Type detectedby PCR Initial source (year)
b Present source
ATCC 3502 (1)a A ATCC (1996) DFEH
ATCC 3502 (2)a A N. Minton, CAMR (2000) IFR
ATCC 19397 (1)a A M. Wictome, CAMR (1997) IFR
ATCC 19397 (2)a A A. East, IFR (1997) IFR
ATCC 19397 (3)a A ATCC (1996) DEFH
ATCC 7948 (1)a A J. Crowther, Unilever (1981) IFR
ATCC 7948 (2)a A T. Roberts, IFR (1993) IFR
ATCC 7948 (3)a A NCTC (1981) (NCTC 3805) IFR
ATCC 7948 (4)a A S. Lindroth, Univ. of Calif. (1989) DEFH
ATCC 7948 (5)a A L. Taylor, TRS (1993) IFR
NCTC 2012 (1)a A NCTC (1993) IFR
NCTC 2012 (2)a A L. Taylor, TRS (1993) IFR
ATCC 25763T (1)a A ATCC (1996) DEFH
ATCC 25763T (2)a A L. Taylor, TRS (1993) IFR
BL81/17 A J. Crowther, Unilever (1981) IFR
BL81/18A A J. Crowther, Unilever (1981) IFR
16037 A LFRA (1981) IFR
96 A A T. Roberts (1993) IFR
CDC1690 A A. East, IFR (1997) IFR
NCTC 3806 A NCTC (1993) IFR
Eyemouth A L. Taylor, TRS (1993) IFR
FT 53 A L. Taylor, TRS (1993) IFR
SL-2 A S. Lindroth, Univ. of Calif. (1989) DEFH
SL-3 A S. Lindroth, Univ. of Calif. (1989) DEFH
SL-4 A S. Lindroth, Univ. of Calif. (1989) DEFH
RS-3 A S. Lindroth, Univ. of Calif. (1989) DEFH
69 A A S. Lindroth, Univ. of Calif. (1989) DEFH
Hall A (CDC) A S. Lindroth, Univ. of Calif. (1989) DEFH
CDC13280 AB A. East, IFR (1997) IFR
NCTC2916 AB M. Wictome, CAMR (1997) IFR
CDC5001 AB C. Hatheway, CDC (1987) IFR
MDa10 AB A. East, IFR (1997) IFR
CDC588 AB A. East, IFR (1993) IFR
ATCC 7949 B ATCC (1996) DEFH
ATCC 17841 B ATCC (1996) DFEH
McClung 133-4803 B S. Lindroth, Univ. of Calif. (1989) DFEH
126 B B Institut Pasteur (1962) DFEH
SL-5 B S. Lindroth, Univ. of Calif. (1989) DEFH
SL-1 B S. Lindroth, Univ. of Calif. (1989) DEFH
4 B B T. Roberts (1993) IFR
FT 239 B L. Taylor, TRS (1993) IFR
BL 150 B Unilever (1986) IFR
BL81/18B B J. Crowther, Unilever (1981) IFR
2345 B J. Crowther, Unilever (1981) IFR
NCTC 3815 B J. Crowther, Unilever (1981) IFR
BL81/25 B LFRA (1981) IFR
ATCC 2743 B ATCC (1981) IFR
BL 143 B Unilever (1986) IFR
CDC15044 B C. Hatheway, CDC (1987) IFR
CDC7827 B C. Hatheway, CDC (1993) IFR
FT 243 B L. Taylor, TRS (1993) IFR
NCIB 4301 B L. Taylor, TRS (1993) IFR
M65/16 B DFEH (soil, 2002) DFEH
M1/3 B DFEH (soil, 2002) DFEH
M170/4 B DFEH (soil, 2003) DFEH
M153/1 B DFEH (soil, 2003) DFEH
M43/15 B DFEH (soil, 2002) DFEH
M193/15 B DFEH (soil, 2003) DFEH
M197/17 B DFEH (soil, 2003) DFEH
He3396 B DFEH (horse feces, 2002) DFEH
He3323 B DFEH (horse feces, 2002) DFEH
ATCC 25764 (1)a F H. Tranter, CAMR (1993) IFR
ATCC 25764 (2)a F ATCC (1996) DFEH
ATCC 35415 (1)a F NCTC (1993) (NCTC 10281) IFR
ATCC 35415 (2)a F P. McClure, Unilever (1993) IFR
F4VI F S. Lindroth, Univ. of Calif. (1989) DFEH
a The same strain was obtained from more than one laboratory, marked 1 to 5.
b ATCC, American Type Culture Collection (Rockville, Md.); DFEH, Department of Food and Environmental Hygiene (Helsinki University); CAMR, Centre for
Applied Microbiology and Research (Salisbury, United Kingdom); IFR, Institute of Food Research (Norwich, United Kingdom); NCTC, National Collection of Type
Cultures (London, United Kingdom); TRS, Torry Research Station; LFRA, Leatherhead Food Research Association; Univ. of Calif., University of California; CDC,
Centers for Disease Control and Prevention.
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solution. The cell suspensions were kept on ice for 1 h, with gentle shaking every
15 min. The cells were then washed twice with PIV buffer and resuspended in 1
ml of double-strength lysis solution (12 mM Tris [pH 7.5], 2 M NaCl, 200 mM
EDTA [pH 8.0], 1% Brij 58, 0.4% deoxycholate, 1% sodium lauroyl sarcosine, 40
l of RNase/ml, 2 mg of lysozyme/ml, 40 U of mutanolysin/ml). A volume of 500
l of each cell suspension was mixed with an equal amount of 2% (wt/vol)
low-melting-point agarose (InCert agarose; Cambrex Bio Science, Rockland,
Maine) and cast in GelSyringe dispensers (New England Biolabs, Beverly,
Mass.). The formed gel plugs were then incubated in lysis solution (6 mM Tris
[pH 7.5], 1 M NaCl, 100 mM EDTA [pH 8.0], 0.5% Brij 58, 0.2% deoxycholate,
0.5% sodium lauroyl sarcosine, 20 l of RNase/ml, 1 mg of lysozyme/ml, 20 U of
mutanolysin/ml) with gentle shaking at 37°C overnight. The next day, the plugs
were rinsed with Tris-EDTA buffer, and the DNA isolation was completed by
washing the plugs twice with ESP (0.5 M EDTA [pH 8.0], 10% sodium lauroyl
sarcosine, 100 g of proteinase K/ml) at 50°C for 3 h. The inactivation of
proteinase K was performed with Pefablock SC (Roche Diagnostics GmbH,
Mannheim, Germany) at 37°C overnight. On the third day, the plugs were
washed with Tris-EDTA buffer twice at 37°C for 2 h with gentle shaking.
The toxin types of the pure cultures were confirmed with multiplex PCR for C.
botulinum, specific for botulinum neurotoxin genes of types A, B, E, and F (12),
and/or using the PCR protocol and primers described previously by Franciosa et
al. (3).
Restriction enzyme digestions and PFGE. Nine rare-cutting restriction en-
zymes, ApaI, AscI, MluI, NruI, PmeI, RsrII, SacII, SmaI, and XhoI (New
England Biolabs), were chosen for testing the cleavage of DNA of proteolytic C.
botulinum. The suitability of the nine enzymes for a molecular epidemiological
analysis was tested by using five strains of proteolytic C. botulinum: two of type
A (ATCC 3502 and ATCC 19397), two of type B (ATCC 2743 and FT 243), and
one of type F (ATCC 25764). Samples were electrophoresed at 8°C through a 1%
(wt/vol) agarose gel (Seakem Gold agarose; BMA, Rockland, Maine) in 0.5
Tris-borate-EDTA buffer (Amresco, Solon, Ohio) at 200 V for 20 to 22 h with a
Gene Navigator system (Pharmacia, Uppsala, Sweden) with a hexagonal elec-
trode. Different pulse time ramps were tested, when necessary, to find the
optimal running conditions. Low Range PFG marker (New England Biolabs)
was used for fragment size evaluation. After the electrophoresis, the gel was
stained for 30 to 45 min in distilled water containing 0.5 g of ethidium bromide/
ml. The gel was rinsed with distilled water and destained in water for at least 2 h.
The DNA fragment sizes were estimated by comparing their running lengths to
those of the molecular weight markers. The gels were photographed by using the
Alpha Imager 2000 documentation system (Alpha Innotech, San Leandro,
Calif.). Each strain was run at least twice with each enzyme.
PFGE pattern analysis. The fingerprint patterns of the 55 strains obtained
with SacII, SmaI, and XhoI were analyzed with BioNumerics software, version
3.5 (Applied Maths, Sint-Martens-Latem, Belgium). The similarity between all
pairs was expressed by the Dice coefficient correlation, and unweighted-pair
group method using average linkages clustering was used for the construction of
the dendrograms. The position tolerance was set at 2.0%, with no increase
towards the end of the pattern, and the optimization value was 0.5%. The
enzyme combinations were formed by numerical analysis combining the un-
weighted pattern information of single restriction enzymes. The discriminatory
ability of different enzymes was calculated by using the discriminatory index (7).
RESULTS
Of the nine enzymes tested, AscI, MluI, and RsrI created
only a few fragments, whereas the majority of the fragments
generated by ApaI and PmeI were too small to allow a reliable
genomic analysis (100 kb) (Fig. 1). NruI showed a varying
performance producing a convenient pattern of fragments with
some strains, but with other strains, there were problems in
interpreting bands that were very close to each other, suggest-
ing duplicate bands. In addition, NruI performed digestions of
the genome of certain strains too frequently, producing several
fragments that were too poorly separated to be reliably ana-
lyzed. Based on the suitable numbers of fragments produced,
SacII, SmaI, and XhoI were chosen for PFGE and cluster
analysis of the 55 strains. With SacII and SmaI, the preferable
pulse time ramp was 1 to 26 s, and the run was completed in
22 h. With XhoI, the optimal pulse time ramp was 1 to 15 s in
18 h.
All the C. botulinum strains investigated resulted in clear
macrorestriction patterns by PFGE. The enzymes SacII, SmaI,
and XhoI produced a suitable fingerprint pattern for a molec-
ular epidemiological analysis, with the number of fragments
ranging from 10 to 22, from 9 to 21, and from 14 to 25,
respectively (Fig. 2 and 3). The smallest fragments included in
the analysis were 48 kb when SacII and SmaI were used and 24
kb when XhoI was used, due to the shorter pulse time ramp
which separated the smaller bands more clearly. The median
number of fragments was 17, 13, and 19 with SacII, SmaI, and
XhoI, respectively.
The similarity levels to differentiate the proteolytic C. botu-
linum serotypes A, B, and F into distinct clusters were 86%
with both SacII and SmaI and 83% with XhoI. The type F
strains were shown to be similar with both SacII and XhoI.
Only with SmaI could the strains be divided into two subgroups
with one band (97 bp) difference. However, according to the
analysis performed with the BioNumerics software, the simi-
larity between the subgroups was higher than 95%; thus, the
strains are considered to form only one cluster (Fig. 4, cluster
FIG. 1. Digestion patterns of type A (ATCC 3502) and type B (FT
243) proteolytic C. botulinum strains using the rare-cutting restriction
enzymes ApaI, AscI, MluI, NruI, PmeI, and RsrII. The pulse time
ramp was 1 to 22 s, and the running time was 20 h. The outermost lanes
and the lane in the middle contain the Low Range PFG marker.
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10). The same strains of type A and type F, which originated
from different laboratories, were shown to be similar with all
three enzymes.
The overall dendrogram showed a high heterogeneity (Fig.
4). With SacII, a total of 33 different PFGE patterns were
produced, and with SmaI and XhoI, the numbers of patterns
were 29 and 32, respectively (Table 2). By combining SacII
with SmaI or with XhoI, an increase in the discriminatory
index compared to the discriminatory index of SacII was noted,
and the number of different PFGE types produced was in-
creased to 38 with XhoI and to 37 with SmaI. When all three
enzymes were combined, the number of PFGE types was 37.
As a whole, the clusters created by the three enzymes over-
lapped significantly. Clusters 1, 2, 3, 5, 9, and 12, created by
using SacII (Fig. 4), were also present in the dendrograms
created by using SmaI and XhoI. Clusters 6 and 7, produced by
SacII (Fig. 4), were also created by using SmaI but combined
to form a single cluster with XhoI. Cluster 11, formed with
SacII, was also created with SmaI, while XhoI differentiated
strain CDC15044 from other strains in this cluster. With SmaI
and XhoI, all the type AB strains were included in a single
cluster, while only two of these strains clustered together when
SacII was used (Fig. 4, cluster 10). However, cluster 4, formed
by SacII, was missed when SmaI or XhoI was used. Also,
instead of cluster 8, as formed by SacII, composed of 126B and
BL81/18B, there was a cluster composed of BL81/18B and
BL81/20 (Fig. 4). In addition, 4B and McClung 133-4803,
which were clearly differentiated with SacII digestion, were
grouped in a cluster with SmaI or XhoI.
Despite the overall heterogeneity, three clusters at the 95%
similarity level consisting of more than three strains of differ-
ent origin were formed, one of the clusters representing type A
strains and two clusters representing type B strains (Fig. 4,
clusters 1, 7, and 11, respectively). Cluster 1 (Fig. 4) comprises
six type A strains, including ATCC 7948, obtained from five
sources. This strain was originally isolated from virgin soil in
the United States in the early part of the 20th century, while
RS-3 and BL81/18A were isolated in the latter part of the 20th
century from Pacific red snapper in the United States and ham
in Europe, respectively. Cluster 11 (Fig. 4) comprises 10 type B
strains from diverse locations. Strains BL150, BL143, and
FT239 are of European origin, while strains CDC15044, NCIB
4301, and ATCC 7949 are of American origin. These strains
are also from different sources, including fish, fruit, and mud.
The other type B cluster was composed of five Finnish soil
samples.
DISCUSSION
Of the nine enzymes tested, SacII, SmaI, and XhoI resulted
in the best fingerprint patterns and may thus be recommended
for the differentiation of proteolytic C. botulinum strains. SacII
produced the highest number of patterns as a single enzyme,
FIG. 2. Digestion patterns of five proteolytic C. botulinum strains,
two of type A (ATCC 3502 and ATCC 19397), two of type B (FT 243
and 4B), and one of type F (ATCC 35415), using the rare-cutting
restriction enzymes SacII and SmaI. The pulse time ramp was 1 to 22 s,
and the running time was 20 h. The outermost lanes and the lane in the
middle contain the Low Range PFG marker.
FIG. 3. Digestion patterns of five proteolytic C. botulinum strains,
two of type A (ATCC 3502 and ATCC 19397), two of type B (FT 243
and 4B), and one of type F (ATCC 35415), using the rare-cutting
restriction enzyme XhoI. The pulse time ramp was 1 to 15 s, and the
running time was 18 h. The outermost lanes contain the Low Range
PFG marker.
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FIG. 4. Dendrogram of 55 proteolytic C. botulinum strains based on digestion patterns obtained with the SacII restriction enzyme.
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and thus, it seems that the use of SacII alone in epidemiolog-
ical analyses would be an adequate and cost-effective choice
for genomic analysis of proteolytic C. botulinum strains. If
further discrimination of the strains or confirmation of strain
similarity is needed, the number of different PFGE types and
the discriminatory power of the method can be increased by
using a combination of SacII and XhoI.
The PFGE method separated all the different toxin types of
proteolytic C. botulinum into distinct clusters or individual
branches at an 86% similarity level with both SacII and SmaI
and at an 83% similarity level with XhoI. There were no spe-
cific fragments associated with type A, type B, or type F strains
that could be used to determine toxin type. In the majority of
cases, PFGE enabled discrimination between individual strains
of proteolytic C. botulinum types A and B.
A total of seven out of nine Finnish isolates possessed sim-
ilar patterns, even though the samples from which the organ-
ism was isolated were from different parts of Finland. They
form only one cluster when XhoI is used and are divided into
two clusters sharing a visually very similar fingerprint pattern
with both SacII (Fig. 4, clusters 6 and 7) and SmaI. Despite the
low number of the isolates studied, this finding might suggest a
higher similarity between strains isolated from a restricted
area, but further studies are needed to confirm this observa-
tion. Less variation in the PFGE patterns of the type B strains
as a whole is noted compared to the patterns of the type A
strains. While 54% of the type B strains were grouped into
clusters containing more than three strains (Fig. 4, clusters 7
and 11), only 32% of type A strains were grouped in this way
(Fig. 4, cluster 1). Interestingly, within clusters 1 and 11 (Fig.
4), there were strains which have been isolated from different
types of materials from two different continents over an extend
period of time. Within the type F strains, a high similarity
between the patterns was observed, but since the number of
the type F isolates available is small, it is not possible to make
any conclusions concerning the pattern homology of type F
strains as a whole.
On seven occasions, a strain which, according to the name,
represented the same isolate was originally derived from more
than one laboratory. These strains have previously been avail-
able in commercial culture collections and, dating back several
decades, they have been exchanged between laboratories and
gone through cycles of sporulation and germination. Even
though these same strains may be considered similar, the fin-
gerprint patterns have slight differences when looked at by the
naked eye due to factors that have an effect on the electro-
phoretic migration of DNA bands (Fig. 4). The appropriate
levels of optimization and tolerance in the numerical analysis
guarantee that these intergel-related differences do not reflect
the pairwise comparison result and dendrogram construction.
The similarity between the fingerprint patterns of the same
strains may suggest a high constancy of the genotype.
Compared to the method described previously for typing
nonproteolytic C. botulinum (5), certain modifications were
necessary when proteolytic C. botulinum strains were typed.
When a volume of 8 ml of culture grown overnight was used for
the DNA isolation, as suggested for nonproteolytic C. botuli-
num (5), the amount of DNA was too high to produce clear
fragments, thus complicating the interpretation of the finger-
prints. To decrease the DNA yield, cells were washed with only
4 ml of tryptone-peptone-glucose-yeast extract broth instead of
8 ml. In addition, a doubled volume of double-strength lysis
solution was used for casting the plugs compared to the pre-
vious protocol. The gels were stained with a solution made in
distilled water, as described previously (14), which was noted
to produce a good resolution of the small fragments. With
nonproteolytic C. botulinum, it has been noted that there are
number of strains, indigestible by SmaI especially, possibly
resulting either from CG methylation or to a lesser extent from
the DNA degradation by endonucleases, as discussed previ-
ously (5, 9). This was not observed for strains of proteolytic C.
botulinum, as all the strains included in this study were type-
able with the three enzymes.
According to a previous report, SacII is not the best alter-
native for strain identification of nonproteolytic C. botulinum
strains, and with certain strains, it has to be replaced by its
isoschizomer, KspI (5). SmaI and XhoI were both among the
five enzymes recommended for the differentiation of the non-
proteolytic C. botulinum strains, but typing of the nonproteo-
lytic C. botulinum using different enzyme combinations has not
been previously reported. As nonproteolytic C. botulinum and
proteolytic C. botulinum represent phylogenetically and phys-
iologically distinct clostridia, it could be expected that the
suitable enzymes for PFGE typing may differ between these
two organisms.
This is the first description of the genetic diversity of pro-
teolytic C. botulinum. Apart from the three distinct clusters
observed, it may be concluded that, as studied by PFGE, pro-
teolytic C. botulinum is a heterogeneous species. This finding
differs from previous observations based on the analysis of 15
strains by RAPD (8). According to the survey (8), five type A
strains (ATCC 3502, ATCC 19397, ATCC 25763, ATCC 7948,
and SL-3) as well as two type B strains (McClung 133-4803 and
ATCC 7949) were confirmed to be similar at the toxin type
level by RAPD, but as demonstrated in our study, these strains
may clearly be discriminated from each other by PFGE. Our
results suggest that the PFGE method is to be considered a
useful tool for studying the epidemiological relatedness of pro-
teolytic C. botulinum isolate types A and B obtained from
patients and from food. However, the possible occurrence of
clusters that share a highly similar PFGE pattern, especially
within the type B strains, should be noted, and therefore,
epidemiological conclusions based on PFGE data only should
be made with discretion. According to our results as well as
those from previous research on the diversity of nonproteolytic
TABLE 2. Discriminatory indices and numbers of clusters and
PFGE profiles of 55 strainsa
Enzymes used No. of PFGEpatterns
No. of
clustersb
Discriminatory
index
SacII 33 12 0.945
SmaI 29 12 0.941
XhoI 32 11 0.941
SacII  SmaI 37 10 0.943
SacII  XhoI 38 10 0.952
SmaI  XhoI 36 11 0.941
SacII  SmaI  XhoI 37 10 0.949
a Produced with different enzymes alone and combined data sets based on an
analysis with BioNumerics software.
b Cluster refers to a group of strains at a 95% similarity level.
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C. botulinum (5, 10), it may be concluded that establishing a
worldwide PulseNet-like databank of C. botulinum could be of
use for the purposes of molecular epidemiological research.
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